IGF-II TREATMENT PREVENTS THE OXIDATIVE DAMAGE DERIVED BY MPP+/MPTP ADMINISTRATION IN A CELLULAR AND ANIMAL MODEL OF PARKINSON’S DISEASE | Publicación